Patents by Inventor Fe Isabel Garcia Maceira

Fe Isabel Garcia Maceira has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190380986
    Abstract: The present invention relates to a high-performance process for obtaining extracts enriched in organosulphur compounds of type S-alkenyl-L-cysteine and S-alkyl-L-cysteine. Said compounds are obtained from plants of the Allium genus and in addition, they are free of sulphoxides. In addition, the use of organosulphur compounds of type S-alkenyl-L-cysteine and S-alkyl-L-cysteine as therapeutic or nutraceutical agents in the prevention and treatment of human and animal diseases that incur in chronic inflammation is described.
    Type: Application
    Filed: January 25, 2018
    Publication date: December 19, 2019
    Inventors: Elier PAZ ROJAS, Fe Isabel GARCIA MACEIRA, Luis Aristides TORRES SANCHEZ, Vanesa RAMIREZ GONZALEZ, Maria Eugenia GARCIA RUBIÑO, Isaac TUNEZ FIÑANA, Ana Isabel GIRALDO POLO, Begoña MarÍa ESCRIBANO DURÁN, Eduardo AGÜERA MORALES, Evelio LUQUE CARABOT
  • Patent number: 9714947
    Abstract: Cell based sensor. The present invention relates to a novel cell based sensor useful for drug discovery that comprises a cell line with professional regulated exocytosis of secretory granules transfected with a non-protease hydrolase as a reporter polypeptide stored in the regulated secretory granules of the cell line with professional regulated exocytosis and having either an endogenous or a heterologous molecule as a modulator of regulated secretory granules exocytosis. Said granule stored non protease-hydrolase reporter having at least: a high resistance to conditions already present inside the granules such as low pH and proteolysis by other proteases; enzymatic activity after exocytosis; a highly specific substrate; absence of toxicity when cell thawing; a very low level of secretion under unstimulated or basal conditions; and a high signal to background activity in a media compatible with cell culture viability and granule exocytosis for a high throughput robust and sensitive detection.
    Type: Grant
    Filed: January 31, 2012
    Date of Patent: July 25, 2017
    Assignee: CANVAX BIOTECH S.L.
    Inventors: Elier Paz Rojas, Fé Isabel García Maceira, Verónica Inmaculada Luna Guerrero, María Gracia Montero Peñalvo, Tania García Maceira, José Andrés Morales Martínez, Ana Belén Aragón Gómez, Ana Quesada Molina, Aurora María Márquez Morales
  • Patent number: 9499584
    Abstract: The present invention surprisingly shows that the addition of a heterologous viral-GPCR (G protein-coupled receptor) derived sequence at the amino terminal end of GPCRs improves cell surface expression of such receptors in eukaryotic cells. Transfected cells expressing the above heterologous viral GPCRs on their surface are useful for cell based assays to identify test compounds that increases or modulate activity of a GPCR or a ligand of a GPCR for example for drug discovery, development of novel flavors in the food industry or development of sensors based on odor GPCRs. In addition, membrane extracts derived from transfected cells may be used for example for assays of compounds in drug discovery or for development of sensors comprising such membrane extracts for identification and/or quantification of volatile organic compounds.
    Type: Grant
    Filed: January 31, 2012
    Date of Patent: November 22, 2016
    Assignee: CANVAX BIOTECH S.L
    Inventors: Elier Paz Rojas, Fé Isabel García Maceira, Verónica Inmaculada Luna Guerrero, Maria Gracia Montero Peñalvo, Tania García Maceira, José Andrés Morales Martínez, Ana Belén Aragón Gómez, Ana Quesada Molina, Aurora María Márquez Morales
  • Patent number: 9347942
    Abstract: The present invention relates to a novel cell based sensor useful for drug discovery that comprises a cell line with professional regulated exocytosis of secretory granules transfected with a protease as a reporter polypeptide stored in the regulated secretory granules of the cell line with professional regulated exocytosis and having either an endogenous or a heterologous molecule as a modulator of regulated secretory granules exocytosis, such said granule stored protease reporter having at least: a high resistance to conditions already present inside the granules such as low pH and proteolysis by other proteases; enzymatic activity after exocytosis; a highly specific cleavage sequence; a very low level of secretion under unstimulated or basal conditions; and a high signal to background activity in a media compatible with cell culture viability and granule exocytosis for a high throughput robust and sensitive detection.
    Type: Grant
    Filed: July 28, 2010
    Date of Patent: May 24, 2016
    Assignee: CANVAX BIOTECH SL
    Inventors: Elier Paz-Rojas, Maria de Gracia Montero-Peñalvo, Veronica Inmaculada Luna-Guerrero, Fe Isabel Garcia Maceira, Jose Andres Morales-Martínez, Tania Garcia Maceira, Ana Belén Aragón-Gómez, Ana Quesada-Molina, Aurora Maria Marquez-Morales
  • Publication number: 20150260724
    Abstract: Cell based sensor. The present invention relates to a novel cell based sensor useful for drug discovery that comprises a cell line with professional regulated exocytosis of secretory granules transfected with a non-protease hydrolase as a reporter polypeptide stored in the regulated secretory granules of the cell line with professional regulated exocytosis and having either an endogenous or a heterologous molecule as a modulator of regulated secretory granules exocytosis. Said granule stored non protease-hydrolase reporter having at least: a high resistance to conditions already present inside the granules such as low pH and proteolysis by other proteases; enzymatic activity after exocytosis; a highly specific substrate; absence of toxicity when cell thawing; a very low level of secretion under unstimulated or basal conditions; and a high signal to background activity in a media compatible with cell culture viability and granule exocytosis for a high throughput robust and sensitive detection.
    Type: Application
    Filed: January 31, 2012
    Publication date: September 17, 2015
    Applicant: CANVAX BIOTECH S.L
    Inventors: Elier Paz Rojas, Fé Isabel García Maceira, Verónica Inmaculada Luna Guerrero, María Gracia Montero Peñalvo, Tania García Maceira, José Andrés Morales Martínez, Ana Belén Aragón Gómez, Ana Quesada Molina, Aurora María Márquez Morales
  • Publication number: 20150175661
    Abstract: The present invention surprisingly shows that the addition of a heterologous viral-GPCR (G protein-coupled receptor) derived sequence at the amino terminal end of GPCRs improves cell surface expression of such receptors in eukaryotic cells. Transfected cells expressing the above heterologous viral GPCRs on their surface are useful for cell based assays to identify test compounds that increases or modulate activity of a GPCR or a ligand of a GPCR for example for drug discovery, development of novel flavors in the food industry or development of sensors based on odor GPCRs. In addition, membrane extracts derived from transfected cells may be used for example for assays of compounds in drug discovery or for development of sensors comprising such membrane extracts for identification and/or quantification of volatile organic compounds.
    Type: Application
    Filed: January 31, 2012
    Publication date: June 25, 2015
    Applicant: CANVAX BIOTECH S.L
    Inventors: Elier Paz Rojas, Fé Isabel García Maceira, Verónica Inmaculada Luna Guerrero, María Gracia Montero Peñalvo, Tania García Maceira, José Andrés Morales Martínez, Ana Belén Aragón Gómez, Ana Quesada Molina, Aurora María Márquez Morales
  • Publication number: 20130203078
    Abstract: The present invention relates to a novel cell based sensor useful for drug discovery that comprises a cell line with professional regulated exocytosis of secretory granules transfected with a protease as a reporter polypeptide stored in the regulated secretory granules of the cell line with professional regulated exocytosis and having either an endogenous or a heterologous molecule as a modulator of regulated secretory granules exocytosis, such said granule stored protease reporter having at least: a high resistance to conditions already present inside the granules such as low pH and proteolysis by other proteases; enzymatic activity after exocytosis; a highly specific cleavage sequence; a very low level of secretion under unstimulated or basal conditions; and a high signal to background activity in a media compatible with cell culture viability and granule exocytosis for a high throughput robust and sensitive detection.
    Type: Application
    Filed: July 28, 2010
    Publication date: August 8, 2013
    Applicant: CANVAX BIOTECH SL
    Inventors: Elier Paz-Rojas, Maria de Gracia Montero-Peñalvo, Veronica Inmaculada Luna-Guerrero, Fe Isabel Garcia Maceira, Jose Andres Morales-Martínez, Tania Garcia Maceira, Ana Belén Aragón-Gómez, Ana Quesada-Molina